Home
    • Plans Blog Contact
    Enovis CORP logo

    Enovis CORP

    ENOV
    Last price US$27.04
    Market cap US$1.5b
    12M price change -0.44%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    ITT INC.ITT Industry peer Smith AO CorporationAOS Industry peer DONALDSON Co INCDCI Industry peer TREX CO INCTREX Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Enovis CORP Overview

    Industry: Specialty Industrial Machinery

    Sector: Industrials

    Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates th Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Enovis CORP into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 07, 2026

    Quarterly result summary

    Net sales was $589M (reported); EPS was $0.89 (reported).

    Net sales $589M reported
    EPS $0.89 reported
    Net income/share -$8.5 reported
    Operating income $6.5M -114% YoY

    What changed

    • Net sales reported to $589M; EPS reported to $0.89.
    • Operating income -114% YoY to $6.5M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 8-K May 07, 2026 SEC filing 10-Q May 07, 2026 SEC filing 10-K Feb 26, 2026 SEC filing 8-K Feb 26, 2026 Earnings release Earnings release Feb 26, 2026 SEC filing 10-Q Nov 06, 2025 SEC filing 8-K Nov 06, 2025 Earnings release Earnings release Nov 06, 2025 SEC filing 10-Q Aug 07, 2025 SEC filing 8-K Aug 07, 2025 Earnings release Earnings release Aug 07, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 2.00/5
    Enovis CORP earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes TREX CO INC Honeywell International Inc Snap-On Inc
    In Specialty Industrial Machinery industry , ITT INC. , Smith AO Corporation , DONALDSON Co INC are companies with high ratings.

    Return on Equity

    Score -0.08/5
    Enovis CORP exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include TREX CO INC Honeywell International Inc Snap-On Inc
    Enovis CORP ENOV US$1.5b
    TREX CO INC TREX US$4.5b
    Honeywell In... HON US$144.6b
    Snap-On Inc SNA US$21.0b

    Net Margin

    Score 0.05/5
    Enovis CORP olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include TREX CO INC Honeywell International Inc Snap-On Inc
    Enovis CORP ENOV US$1.5b
    TREX CO INC TREX US$4.5b
    Honeywell In... HON US$144.6b
    Snap-On Inc SNA US$21.0b

    Share Buyback

    In Specialty Industrial Machinery industry , ITT INC. , Smith AO Corporation , DONALDSON Co INC are companies with high ratings.

    Leverage

    Score 3.12/5
    Enovis CORP attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as TREX CO INC Honeywell International Inc Snap-On Inc , also exhibit high scores.
    Enovis CORP ENOV US$1.5b
    TREX CO INC TREX US$4.5b
    Honeywell In... HON US$144.6b
    Snap-On Inc SNA US$21.0b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Enovis CORP logo

    Enovis CORP

    US$27.04

    US$1.5b

    -0.07%

    -0.44%